GraphkmerDTA:集成局部序列模式和拓信息,用于药物标结合亲缘关系的预测和在多标抗阿尔茨海默氏症药物发现中的应用
Zuolong Zhang1, Gang Luo2, Yixuan Ma3
1School of Software, Henan University, Kaifeng, 475000, Henan, China.
Molecular diversity
|January 10, 2025
概括
一种新的AI模型GraphkmerDTA通过整合Kmer和结构特征来增强药物发现,以准确地预测药物标的结合亲和力. 它的性能优于现有的方法,并且在识别癌症药物和阿尔茨海默病治疗中显示出实际应用.
科学领域:
- 计算化学是一种计算化学.
- 人工智能在药物发现中的作用
- 生物信息学是一种生物信息学.
背景情况:
- 准确的药物标结合亲和力 (DTA) 预测对于有效的早期药物发现至关重要.
- 现有的基于序列的方法可能会因固定长度特征的提取而导致信息丢失.
- 基于结构的方法往往无法捕获必要的序列信息.
研究的目的:
- 开发一个新的深度学习模型,GraphkmerDTA,克服现有的DTA预测方法的局限性.
- 将克默序列特征与蛋白质和分子结构拓集成,以改进DTA预测.
- 为了证明GraphkmerDTA在药物发现和机制研究中的实际实用性.
主要方法:
- 图形神经网络 (GNN) 用于从分子和蛋白质结构中提取拓特征.
- 完全连接的网络被用来从蛋白质克默特征中学习局部序列模式.
- GraphkmerDTA模型集成了GNN和基于Kmer的特征学习,用于DTA预测.
主要成果:
- 在DTA预测的基准数据集上,GraphkmerDTA显著优于现有的方法.
- 该模型成功地从肺癌病例研究中的大型查库中识别出七种已知的EGFR抑制剂.
- 与网络药理学的整合,确定并验证了阿尔茨海默病的潜在治疗化合物.
结论:
- GraphkmerDTA代表了用于DTA预测的新型AI方法,有效地结合了序列和结构信息.
- 该模型在识别候选药物和阐明治疗机制方面证明了其实际适用性.
- 这项工作突出了先进的人工智能技术和传统药物发现方法之间的协同作用.
相关概念视频
02:04Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
01:28Structure-Activity Relationships and Drug Design
494
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
494
01:26Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
01:49Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
02:40Ligand Binding Sites
12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
00:49Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K